Addictive disorders are a group of disorders that can cause physical and psychological damage. Receiving treatment is essential for breaking the cycle of addiction.
However, as a chronic disease, addiction is difficult to treat and requires on-going care.
In the United States, around 8.1 percent of the population, or 21.7 million people, either need or regularly receive treatment for substance use disorders, according to the National Survey on Drug Use and Health.
The first step towards recovery is acknowledging that substance use has become a problem in the person’s life which is disrupting the quality of their life. This can result from impairment in school, work, social, recreational or other important areas of function.
Full story at Medical News Today
Google has announced it is restricting ads for addiction treatment. “We found a number of misleading experiences among rehabilitation treatment centers that led to our decision,” a company spokeswoman said.
Prosecutors and health advocates have warned that many online searches for addiction treatment lead people to click on ads for rehab centers that are not suited to help them, or may even endanger their lives, according to The New York Times. Many rehab centers buy ads that would come up when someone searched for phrases such as “alcohol treatment centers” or “drug rehab.”
Full story at drugfree.org
Only one in four young adults and teens with opioid use disorder (OUD) are receiving potentially life-saving medications for addiction treatment, according to a new Boston Medical Center (BMC) study published online in JAMA Pediatrics.
Buprenorphine and naltrexone are medications used to treat OUD that help prevent relapse and overdose when used appropriately. In late 2016, the American Academy of Pediatrics recommended, for the first time, that providers offer medication treatment to adolescents with OUD.
Prior studies have shown that among all adults in treatment for opioids, one-third started using opioids before age 18, and two-thirds started before age 25. Unlike methadone, buprenorphine and naltrexone can be offered in the primary care setting. However, few teens receive medication due, in part, to a widespread shortage of physicians who have received a waiver certification required to prescribe buprenorphine. And, as researchers note, of all of the physicians who are certified in the United States, only one-percent are pediatricians.
Full story of treating young people with opioid use disorder at drugfree.org
Cuts to Medicaid proposed by Republicans in the U.S. House and Senate jeopardize addiction treatment, NPR reports.
In Pennsylvania, more than 124,000 residents depend on Medicaid for addiction treatment. The state’s Medicaid program currently pays for addiction treatment with Vivitrol, a monthly injection that costs about $1,000 a dose. A person receiving the shots also has weekly therapy sessions and visits with a recovery coach, also paid for by Medicaid. Pennsylvania, which expanded Medicaid under the Affordable Care Act, pays no more than 10 percent of costs for patients who gained coverage under the expansion. The federal government funds the rest.
Full story of proposed Medicaid cuts and addiction treatment at drugfree.org
Addiction treatment advocates are trying to convince Republican legislators in states greatly impacted by the opioid epidemic to protect insurance coverage for substance abuse treatment if the Affordable Care Act (ACA) is repealed.
Repealing the ACA without having a plan in place to preserve coverage would weaken efforts to address the opioid crisis, according to Gary Mendell, founder of Shatterproof, a nonprofit that advocates for legislation to fight addiction. Shatterproof is working with the National Council for Behavioral Health, which represents 2,800 providers of mental health and addiction treatment, The Wall Street Journal reports.
Full story of advocates trying to protect coverage for addiction treatment at drugfree.org